The global challenge of HIV/AIDS remains one of the most pressing public health issues today. According to the latest data from UNAIDS, around 38.4 million people worldwide are living with HIV/AIDS, underlining the need for not only medical intervention but also comprehensive awareness, education, and social change. Despite the significant strides made in treatment and prevention, the confusion surrounding the relationship between HIV and AIDS still persists.

Young people have become influential advocates in the fight against HIV/AIDS. Research from UNICEF shows that youth-led initiatives can lower HIV transmission rates by as much as 45% in targeted communities. These young activists utilize digital platforms and peer-to-peer education to dispel myths, promote safe practices, and foster supportive environments for those affected by HIV/AIDS.

Dr Gowri Kulkarni, an expert in Internal Medicine, explains that while the terms HIV and AIDS are often used interchangeably, they are distinctly different. "HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system, whereas AIDS (Acquired Immunodeficiency Syndrome) is a condition that occurs when HIV severely damages the immune system," she clarifies. To understand the implications of these differences, it's important to explore the fundamental distinctions between the two.

1. HIV is a Virus; AIDS is a Syndrome

HIV is the virus responsible for attacking the body’s immune system, specifically targeting CD4 cells, which are crucial for the body’s defense against infections. As HIV progresses, it destroys these cells, weakening the immune system over time. If left untreated, this continuous damage can lead to AIDS.

AIDS, on the other hand, is a syndrome, not a virus. Dr Kulkarni further elaborates that AIDS is a collection of symptoms and illnesses that emerge when the immune system is severely compromised due to prolonged HIV infection. It represents the most advanced stage of HIV, and is characterized by very low CD4 counts or the onset of opportunistic infections like tuberculosis, pneumonia, or certain cancers.

2. Not Everyone with HIV Develops AIDS

A key distinction to remember is that not everyone with HIV will progress to AIDS. Thanks to advancements in medicine, particularly antiretroviral therapy (ART), individuals living with HIV can manage the virus and maintain a healthy immune system for many years, or even decades, without ever developing AIDS. ART works by suppressing the virus to undetectable levels, effectively preventing the damage HIV would otherwise cause to the immune system.

Without treatment, however, HIV progresses through three stages:

- Acute HIV Infection: This stage occurs shortly after transmission and may include symptoms like fever, fatigue, and swollen lymph nodes.

- Chronic HIV Infection: Often asymptomatic or mildly symptomatic, the virus continues to damage the immune system but at a slower rate.

- AIDS: This is the final stage, marked by severe immune damage and the presence of infections that take advantage of the compromised immune defenses.

3. HIV is Transmissible; AIDS is Not

Another key distinction between HIV and AIDS is the way in which they are transmitted. HIV is highly contagious and can be transmitted through the exchange of bodily fluids such as blood, semen, vaginal fluids, and breast milk. It is primarily spread through unprotected sexual contact, sharing needles, or from mother to child during childbirth or breastfeeding.

AIDS, however, is not transmissible. It is not a disease that can be passed from one person to another. Rather, AIDS is the result of untreated, advanced HIV infection and is a direct consequence of the virus’s damage to the immune system.

4. Diagnosis Methods Differ

HIV and AIDS are diagnosed through different methods. HIV is diagnosed through blood tests or oral swabs that detect the presence of the virus or antibodies produced by the immune system in response to the virus. Early detection of HIV is crucial, as it allows for timely intervention and treatment, which can prevent the virus from progressing to AIDS.

AIDS, on the other hand, is diagnosed using more specific criteria. Dr Kulkarni notes that the diagnosis of AIDS is made when the individual’s CD4 cell count falls below 200 cells/mm³, or when opportunistic infections or certain cancers (such as Kaposi's sarcoma or lymphoma) are detected. Diagnosing AIDS involves a more thorough assessment of the individual’s immune function and overall health, as opposed to just the detection of HIV.

5. Treatment Goals Are Different

The treatment goals for HIV and AIDS differ significantly, although both involve antiretroviral therapy (ART). For HIV, the primary treatment goal is to suppress the virus to undetectable levels, thus maintaining a strong immune system and preventing further transmission of the virus. People living with HIV can often live long, healthy lives if they adhere to ART.

For individuals diagnosed with AIDS, the treatment plan becomes more complex. While ART remains an essential part of managing the virus, treatment for AIDS also focuses on addressing the opportunistic infections and secondary health complications associated with severe immune suppression. The goal of treatment for AIDS is not only to manage the HIV virus but also to improve the quality of life and extend survival by treating these secondary health issues.

Role of Community Engagement in Combatting HIV/AIDS

While the medical community has made great strides in managing HIV, the battle to curb its transmission is also a social and cultural issue. Dr Daman Ahuja, a public health expert, highlights that HIV/AIDS awareness and education are vital to reducing transmission rates and supporting those affected by the virus. "Young people, especially, have become key advocates in the fight against HIV/AIDS," says Dr Ahuja. "Research from UNICEF shows that youth-led initiatives can lower HIV transmission rates by as much as 45% in targeted communities."

Additionally, grassroots activism plays a significant role in raising awareness and addressing stigma. As the World Health Organization reports, community-based interventions have been proven to increase HIV testing rates and improve treatment adherence, which are crucial in the fight against the pandemic.

The ultimate goal of organizations like UNAIDS is to eliminate the HIV/AIDS pandemic by 2030. Achieving this requires global collaboration, from medical treatment advancements to public health strategies, education, and advocacy. Dr Kulkarni’s insight underscores the importance of early detection, treatment adherence, and community support in the fight against HIV/AIDS.

Dr Gowri Kulkarni is Head of Medical Operations at MediBuddy and Dr Daman Ahuja, a public health expert and has been associated with Red Ribbon Express Project of NACO between 2007-12.

GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and liraglutide, best known for regulating appetite and aiding weight loss, may also help reduce symptoms of binge eating disorder (BED), which affects more than 17 million people worldwide, according to a new study.

The systematic review and meta-analysis, published in the journal eClinicalMedicine, found that GLP-1 drugs, with semaglutide as its key ingredient, reduced binge eating episodes, loss-of-control eating and emotional eating, highlighting their potential role in treating binge eating disorder alongside obesity.

Binge eating disorder affects over 17 million people globally, and around two-thirds of people with the condition also live with overweight or obesity. It is also common among individuals seeking weight-loss treatment.

"Binge eating disorder, where people regularly eat an excessive amount of food while feeling they have lost control, is common and highly impairing, affecting over 17 million people worldwide," said lead author Dr Ilaria Costantini from the Psychiatry Department at University College London (UCL), UK.

"But treatment options are limited and there are currently no approved medications, so there remains a need for better ways to help people living with this condition. We found evidence that weight loss drugs may help to manage some key symptoms of binge eating disorder," Costantini added.

Also read: Babies Without Vitamin K Shot At Higher Risk Of Brain Bleeding: Study

What Did The Study Find?

The researchers analyzed 25 randomized controlled trials conducted across 12 countries on four continents, involving 8,069 participants.

The trials evaluated GLP-1 drugs that target the appetite-regulating hormone GLP-1, including semaglutide (marketed as Ozempic or Wegovy), tirzepatide (Mounjaro) and liraglutide.

These medications suppress appetite by acting on the central nervous system and insulin secretion, delay stomach emptying, and may also influence brain pathways involved in reward and impulse control.

Compared with placebo or other treatments, people taking GLP-1 drugs reported:

• Moderate reductions in binge eating severity
• Reduced loss-of-control eating
• Lower levels of uncontrolled eating
• Reduced emotional eating

Read More: Obesity-Driven CKM Syndrome A Growing Public Health Threat, Warns American Heart Association

The researchers also found that participants taking GLP-1 drugs reported greater cognitive or dietary restraint, meaning they made more deliberate efforts to limit what they ate.

The benefits extended beyond weight loss, with improvements seen in several behaviors associated with binge eating disorder.

More Research Needed on Dietary Restraint

While increased dietary restraint was observed, the researchers cautioned that it remains unclear whether this represents healthy self-regulation or a more rigid, potentially harmful eating pattern that could worsen binge eating over time.

"From the evidence available, we cannot say whether the increase in dietary restraint reflects a positive and helpful form of self-regulation or if it is a more dysfunctional pattern of eating. We hope that future research can clarify whether or not taking weight loss drugs might contribute to more pathological forms of eating restriction such as meal skipping," said Izzy Emptage from UCL Psychiatry.

Researchers Urge Caution

The researchers said GLP-1 drugs could become an important addition to treatment plans for binge eating disorder when used alongside psychological therapies and social support.

However, they also highlighted important limitations. Most of the studies included in the review had a high risk of bias, were funded by pharmaceutical companies, and rarely included participants with a clinical diagnosis of binge eating disorder, reducing the certainty of the findings.

"GLP-1s may offer a promising additional treatment option for people living with both binge eating and obesity," the researchers said, while stressing that these drugs "should not be viewed as a standalone solution to binge eating disorder."

They added that larger, independently funded clinical trials are needed before these medications can be routinely recommended for treating binge eating disorders.

What if staying younger has less to do with expensive anti-aging products and more to do with spending time appreciating the culture. A new study suggests that regular cultural outings may be linked to slower biological aging.

A Trip To The Museum Could Slow Your Biological Age

Expect an unexpected addition to the list of healthy lifestyle habits. Researchers recently found that older adults who frequently visited museums, theaters, cinemas, concerts, and art galleries physically functioned as if they were about three years younger than those who didn’t take part in such activities.

Published in the Journal of Epidemiology and Community Health, the researchers say that cultural interaction appears to be associated with a younger physiological age, although the study does not prove that cultural activities directly contribute to slow aging.

What The Researchers Found?

The study analyzed data from 1,899 adults aged 50 years and older who participated in the English Longitudinal Study of Ageing. Participants reported how often they:

• Visited museums or art galleries
• Went to the cinema
• Attended theaters, concerts, or the opera

Also read: Anti-Inflammatory Diet May Help Lower Dementia Risk, Even In Those Who Show Early Signs Of Alzheimer’s: Study

Researchers also assessed 10 health indicators, including:

• Blood pressure
• Cholesterol
• Lung function
• Body mass index (BMI)
• Grip strength
• Walking speed
• Blood markers linked to aging

These measures were combined to ascertain each participant's physiological age.

People who participated in cultural activities every few months or more had an average physiological age of 66.9 years, compared with 69.9 years among those with lower levels of cultural engagement, a difference of roughly three biological years.

The researchers also found that every one-point increase in a person's cultural engagement score was associated with approximately a 31-day reduction in physiological age, even after accounting for income, employment, and chronic health conditions.

Also read: Bryan Johnson Plans To Create 'Bryan In A Dish' Living Lab To Test Experimental Autoimmune Treatments

Why Might Cultural Activities Help Slow Aging?

Although the study wasn't designed to identify a direct cause, the researchers suggest several possible explanations that can help reduce biological age. Cultural activities may help:

• Strengthen social connections
• Reduce loneliness
• Improve mental well-being
• Encourage people to stay physically active
• Reduce chronic stress

Interestingly, the researchers noted that the association between cultural engagement and slower aging was comparable to the benefits seen with frequent physical activity, highlighting that healthy aging may involve much more than exercise alone.

Culture And Longevity

The latest findings add to a growing body of research suggesting that spending time on cultural activities may benefit both the brain and the body as people age.

Previous studies have found that older adults who regularly visit museums, art galleries, theaters, concerts, and similar cultural spots may have a lower risk of dementia, experience slower cognitive decline, and even live longer than those who rarely engage in such activities.

For example, a 2019 study published in The BMJ reported that adults over 50 who participated in cultural activities every few months or more had a 31% lower risk of death during a 14-year follow-up compared with those who never took part.

Another study from University College London found that frequent museum visits were associated with a reduced risk of developing dementia over the following decade.

The growing trend of medical tourism or cosmetic tourism has become increasingly popular in the age of social media. The dramatic before-and-after results, the thrill of returning home with a new look, and a quenched wanderlust have only contributed to this trend.

While the appeal is evident, we cannot help but ignore the risks and complications one can face while traveling overseas for a cosmetic procedure. On World Plastic Surgery Day, take a look at what you are in for if you are planning to fly off for a procedure.

Why People Travel Abroad For Cosmetic Procedures?

One of the biggest reasons why people travel abroad for cosmetic procedures is the cost. Procedures like liposuction, tummy tucks, breast enhancement, rhinoplasty, and dental veneers can cost almost 30% to 70% less in some countries than in the United States, United Kingdom, or Australia.

Many cosmetic packages also come with other attractive deals like luxury recovery packages, airport transfers, and hotel stays, combined vacation and surgery experiences, among others.

For some patients, these deals make cosmetic procedures more affordable and convenient. However, lower prices do not always necessarily mean lower quality. But the concern is that patients do not adequately evaluate the standards of clinics before they travel.

Also read: Plastic Surgery Myths Debunked: Experts Explain Cosmetic vs Reconstructive Surgery

Hidden Risks And Complications

Here are some risks and complications that one ought to be aware of before booking those flight tickets.

Infections And Delayed Wound Healing

Patients who fly home too soon may experience wound breakdown, excessive swelling, or bleeding that requires urgent medical attention.

Dr Banodkar says, “Unqualified practitioners, who perform these procedures, may not be adequately trained; they might cause a permanent scar on the skin, or they might even cause a simple infection of the skin that can result in sepsis.”

Unsatisfactory Results

Every surgery carries the possibility of asymmetry, scarring, implant problems, or the need for revision surgery due to unqualified or unskilled practitioners. This could incur hidden costs of corrective surgeries.

Dr. Pravin Banodkar, Consultant Dermatologist, Saifee Hospital, Mumbai, told HealthandMe, “There are hidden costs of any corrective treatment which can obviously be much more than what is actually spent for the procedure.”

Limited Follow-Up Care

Many cosmetic procedures require multiple follow-up visits, wound checks, suture removal, and monitoring complications.

Patients returning home shortly after surgery may have limited access to the operating surgeon. Local doctors may also be unfamiliar with the exact techniques or implants used, making management more challenging.

Also read: How Reconstructive Plastic Surgery Transforms Lives After Trauma And Cancer

Limited Legal Protection

Dr Banodkar explains, “Many times, the people who are not trained don't know how to manage complications, and as a result, they are unable to diagnose the problem. Due to this, the adverse effects of the procedure will only increase.”

If complications occur, seeking compensation or legal action across international borders can be difficult and expensive, as medical regulations, malpractice laws, and patient protections vary widely between countries.